Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Butler

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The Lancet. Psychiatry|January 9, 2018
Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): a pragmatic, randomised controlled, superiority trialPeter Fonagy, Stephen Butler, David Cottrell, et al.
The Lancet. Psychiatry|February 20, 2025
Mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales (Mentalization for Offending Adult Males, MOAM): a multicentre, assessor-blinded, randomised controlled trialPeter Fonagy, Elizabeth Simes, Karen Yirmiya, et al.
Psychological Medicine|April 2, 2024
The mediating role of reflective functioning and general psychopathology in the relationship between childhood conduct disorder and adult aggression among offendersKaren Yirmiya, Matthew Constantinou, Elizabeth Simes, et al.
The Journal of Pediatrics|February 17, 2015
A randomized clinical trial of therapeutic hypothermia mode during transport for neonatal encephalopathyVishnu Priya Akula, Priscilla Joe, Kajori Thusu, et al.
The Lancet. Psychiatry|May 1, 2020
Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): 5-year follow-up of a pragmatic, randomised, controlled, superiority trialPeter Fonagy, Stephen Butler, David Cottrell, et al.
Elife|March 20, 2024
Inhibition of <i>CERS1</i> in skeletal muscle exacerbates age-related muscle dysfunctionMartin Wohlwend, Pirkka-Pekka Laurila, Ludger J E Goeminne, et al.
Pediatric Pulmonology|May 15, 2003
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes RegistryCurt Parnes, Judith Guillermin, Rolf Habersang, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Lancet. Psychiatry|January 9, 2018
Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): a pragmatic, randomised controlled, superiority trialPeter Fonagy, Stephen Butler, David Cottrell, et al.
The Lancet. Psychiatry|February 20, 2025
Mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales (Mentalization for Offending Adult Males, MOAM): a multicentre, assessor-blinded, randomised controlled trialPeter Fonagy, Elizabeth Simes, Karen Yirmiya, et al.
Psychological Medicine|April 2, 2024
The mediating role of reflective functioning and general psychopathology in the relationship between childhood conduct disorder and adult aggression among offendersKaren Yirmiya, Matthew Constantinou, Elizabeth Simes, et al.
The Journal of Pediatrics|February 17, 2015
A randomized clinical trial of therapeutic hypothermia mode during transport for neonatal encephalopathyVishnu Priya Akula, Priscilla Joe, Kajori Thusu, et al.
The Lancet. Psychiatry|May 1, 2020
Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): 5-year follow-up of a pragmatic, randomised, controlled, superiority trialPeter Fonagy, Stephen Butler, David Cottrell, et al.
Elife|March 20, 2024
Inhibition of <i>CERS1</i> in skeletal muscle exacerbates age-related muscle dysfunctionMartin Wohlwend, Pirkka-Pekka Laurila, Ludger J E Goeminne, et al.
Pediatric Pulmonology|May 15, 2003
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes RegistryCurt Parnes, Judith Guillermin, Rolf Habersang, et al.
Pageof 7